FMS
Get informed when a big investor buys or sells
+ FollowUndervalued by 66.1% based on the discounted cash flow analysis.
| Market cap | $12.36 Billion |
|---|---|
| Enterprise Value | $22.31 Billion |
| Dividend Yield | $0.86 (3.76%) |
| Earnings per Share | $1.68 |
| Beta | 0.81 |
| Outstanding Shares | 550,492,690 |
| P/E Ratio | 11.55 |
|---|---|
| PEG | -51.86 |
| Price to Sales | 0.67 |
| Price to Book Ratio | 0.94 |
| Enterprise Value to Revenue | 1.15 |
| Enterprise Value to EBIT | 13.22 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 0.84 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 4.2857▲ 428.57% |
|---|---|
| Total Calls | 24,500▲ Infinity% |
| Total Puts | 105,000▲ 150.60% |
Holdings and activity of institutional investors.
| Ownership % | 7.23%▲ 0.81% |
|---|---|
| Total Invested | $950.45M▲ 6.28% |
| Investors Holding | 221▲ 6.00% |
No data
As the primary committee for taxation, trade, and entitlement spending (Medicare/Medicaid), it directly controls the reimbursement rates and tax policies that critically impact Fresenius Medical Care's profitability and operations.
This committee allocates discretionary federal spending, with its subcommittees directly determining the precise funding levels for Medicare, Medicaid, and other healthcare programs crucial to Fresenius Medical Care's revenue.
This committee directly regulates the FDA (medical devices/drugs), NIH (research), and labor laws, all of which critically impact the operations, costs, and product offerings of Fresenius Medical Care.
This committee drafts the budget resolution that sets overall federal spending ceilings, critically influencing funding for Medicare and Medicaid, which are primary revenue sources for kidney dialysis centers.
This committee oversees federal contracting and government efficiency, directly impacting healthcare providers like Fresenius Medical Care who rely heavily on Medicare and Medicaid reimbursement, which are major federal expenditures.